185 related articles for article (PubMed ID: 33121353)
1. Involvement of cannabinoid type 1 receptor in fasting-induced analgesia.
Lee JY; Lee GJ; Nakamura A; Lee PR; Kim Y; Won CH; Furue H; Oh SB
Mol Pain; 2020; 16():1744806920969476. PubMed ID: 33121353
[TBL] [Abstract][Full Text] [Related]
2. Acetaminophen Relieves Inflammatory Pain through CB
Klinger-Gratz PP; Ralvenius WT; Neumann E; Kato A; Nyilas R; Lele Z; Katona I; Zeilhofer HU
J Neurosci; 2018 Jan; 38(2):322-334. PubMed ID: 29167401
[TBL] [Abstract][Full Text] [Related]
3. Histone methyltransferase G9a diminishes expression of cannabinoid CB
Luo Y; Zhang J; Chen L; Chen SR; Chen H; Zhang G; Pan HL
J Biol Chem; 2020 Mar; 295(11):3553-3562. PubMed ID: 32024693
[TBL] [Abstract][Full Text] [Related]
4. Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia.
Santos-Molina L; Herrerias A; Zawatsky CN; Gunduz-Cinar O; Cinar R; Iyer MR; Wood CM; Lin Y; Gao B; Kunos G; Godlewski G
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443679
[TBL] [Abstract][Full Text] [Related]
5. Role of primary sensory neurone cannabinoid type-1 receptors in pain and the analgesic effects of the peripherally acting agonist CB-13 in mice.
Ford NC; Barpujari A; He SQ; Huang Q; Zhang C; Dong X; Guan Y; Raja SN
Br J Anaesth; 2022 Jan; 128(1):159-173. PubMed ID: 34844727
[TBL] [Abstract][Full Text] [Related]
6. Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms.
Peng X; Studholme K; Kanjiya MP; Luk J; Bogdan D; Elmes MW; Carbonetti G; Tong S; Gary Teng YH; Rizzo RC; Li H; Deutsch DG; Ojima I; Rebecchi MJ; Puopolo M; Kaczocha M
Mol Pain; 2017 Jan; 13():1744806917697007. PubMed ID: 28326944
[TBL] [Abstract][Full Text] [Related]
7. A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain.
Yu XH; Cao CQ; Martino G; Puma C; Morinville A; St-Onge S; Lessard É; Perkins MN; Laird JMA
Pain; 2010 Nov; 151(2):337-344. PubMed ID: 20696525
[TBL] [Abstract][Full Text] [Related]
8. The analgesic effect of refeeding on acute and chronic inflammatory pain.
Lee JY; Lee GJ; Lee PR; Won CH; Kim D; Kang Y; Oh SB
Sci Rep; 2019 Nov; 9(1):16873. PubMed ID: 31727949
[TBL] [Abstract][Full Text] [Related]
9. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
Mol Pain; 2016; 12():. PubMed ID: 27178246
[TBL] [Abstract][Full Text] [Related]
10. N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism.
Okine BN; Madasu MK; McGowan F; Prendergast C; Gaspar JC; Harhen B; Roche M; Finn DP
Pain; 2016 Dec; 157(12):2687-2696. PubMed ID: 27649266
[TBL] [Abstract][Full Text] [Related]
11. Functional blockage of the cannabinoid receptor type 1 evokes a kappa-opiate-dependent analgesia.
Sáez-Cassanelli JL; Fontanella GH; Delgado-García JM; Carrión AM
J Neurochem; 2007 Dec; 103(6):2629-39. PubMed ID: 17953671
[TBL] [Abstract][Full Text] [Related]
12. Sinomenine produces peripheral analgesic effects via inhibition of voltage-gated sodium currents.
Lee JY; Yoon SY; Won J; Kim HB; Kang Y; Oh SB
Neuroscience; 2017 Sep; 358():28-36. PubMed ID: 28663089
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists.
Veeraraghavan P; Nistri A
Neuroscience; 2015 Sep; 303():16-33. PubMed ID: 26126926
[TBL] [Abstract][Full Text] [Related]
14. Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain.
Mitrirattanakul S; Ramakul N; Guerrero AV; Matsuka Y; Ono T; Iwase H; Mackie K; Faull KF; Spigelman I
Pain; 2006 Dec; 126(1-3):102-14. PubMed ID: 16844297
[TBL] [Abstract][Full Text] [Related]
15. A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Suplita RL; Hohmann AG
Neuroscience; 2003; 117(3):659-70. PubMed ID: 12617970
[TBL] [Abstract][Full Text] [Related]
16. Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain.
Zhang H; Lund DM; Ciccone HA; Staatz WD; Ibrahim MM; Largent-Milnes TM; Seltzman HH; Spigelman I; Vanderah TW
Pain; 2018 Sep; 159(9):1814-1823. PubMed ID: 29781960
[TBL] [Abstract][Full Text] [Related]
17. Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice.
Tai S; Vasiljevik T; Sherwood AM; Eddington S; Wilson CD; Prisinzano TE; Fantegrossi WE
Drug Alcohol Depend; 2018 Nov; 192():285-293. PubMed ID: 30300803
[TBL] [Abstract][Full Text] [Related]
18. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence.
Trang T; Ma W; Chabot JG; Quirion R; Jhamandas K
Pain; 2006 Dec; 126(1-3):256-71. PubMed ID: 16935424
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Cannabinoid Receptor 1 Can Influence the Lipid Metabolism in Mice with Diet-Induced Obesity.
Wei LW; Yuan ZQ; Zhao MD; Gu CW; Han JH; Fu L
Biochemistry (Mosc); 2018 Oct; 83(10):1279-1287. PubMed ID: 30472964
[TBL] [Abstract][Full Text] [Related]
20. CB
Drori A; Gammal A; Azar S; Hinden L; Hadar R; Wesley D; Nemirovski A; Szanda G; Salton M; Tirosh B; Tam J
Elife; 2020 Nov; 9():. PubMed ID: 33210603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
